AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Chronic Pruritus: Diagnosis and Management

Description

The transcript discusses chronic pruritus, emphasizing its significant impact on patients' lives and the complexities involved in its diagnosis and management. It starts with a personal experience of a speaker suffering from chronic spontaneous urticaria (CSU) and the electric sensation associated with itching. The speaker outlines the difficulty dermatologists face in treating itch, which can be related to various conditions like atopic dermatitis, prurigo nodularis, and neuropathic itch, among others. The presentation includes strategies for patient evaluation, such as considering the duration of the itch, atopic history, and systemic causes, while advocating for a thorough workup including blood tests and imaging when needed. Case studies exemplify approaches to diagnosing causes of chronic itch and exploring treatment options, including topical agents and systemic therapies like dupilumab and naltrexone. Emerging treatments, the potential role of eosinophils in evaluating itch, and the importance of patient feedback in treatment outcomes are also noted. The session concludes with a call for further insights into managing chronic itch and highlights the evolving understanding of its underlying mechanisms.

View more

Conclusions

  • Chronic pruritus significantly impacts patients' quality of life and can be as debilitating as other serious medical conditions.
  • Diagnosis of chronic itch should involve a comprehensive evaluation, including history-taking and physical examination.
  • Different diseases can present with similar itch patterns, indicating the need for a thorough differential diagnosis.
  • It is crucial to identify and manage underlying causes of chronic itch, including systemic and neurologic factors, to provide effective treatment.
  • A structured approach to workup is necessary for chronic itch, including appropriate laboratory testing for systemic causes and potential malignancies.
  • Blood eosinophil counts and IgE levels may serve as helpful biomarkers for assessing chronic itch and guiding treatment decisions.
  • Unique management strategies, such as opioids and cannabinoids, may offer relief for patients who fail conventional therapies.
  • Dupilumab shows promise in treating chronic itch by impacting the underlying immune mechanisms associated with pruritus.
  • Whang et al., Kwatra SG. J Invest Dermatol. 2021; 754-760.
  • Roh YS, Choi J, Sutaria N, Kwatra SG. Itch: Epidemiology, clinical presentation, and diagnostic workup. J Am Acad Dermatol. 2022;86(1):1-14.
  • Patel et al., Kwatra SG. Cholestatic Pruritus: Emerging Mechanisms and Therapeutics. J Am Acad Dermatol. 2019.
  • Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol. 2006;54(3):527-531.
  • Khanna R, Kwon CD, Patel SP, et al. Intranasal butorphanol rescue therapy for the treatment of intractable pruritus: A case series from the Johns Hopkins Itch Clinic. J Am Acad Dermatol. 2020;83(5):1529-1533.
  • Golpanian RS, Yosipovitch G, Levy C. Use of Butorphanol as Treatment for Cholestatic Itch. Dig Dis Sci. 2021;66(5):1693-1699.
  • Kwatra SG, Yosipovitch G, Legat FJ, et al. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. N Engl J Med. 2023;389(17):1579-1589.
  • Roh YS, Khanna R, Patel SP, et al. Circulating blood eosinophils as a biomarker for variable clinical presentation and therapeutic response in patients with chronic pruritus of unknown origin. Itch. 2024;9(1):e0073.
  • Fett N, Haynes K, Propert KJ, Margolis DJ. Predictors of malignancy development in patients with chronic pruritus. J Dermatol Sci. 2016;82(2):123-128.
  • Johannesdottir SA, Farkas DK, Vinding GR, et al. Cancer incidence among patients with a hospital diagnosis of pruritus: a nationwide Danish cohort study. Br J Dermatol. 2014;171(4):839-846.